Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|August 16, 2011
Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemiaStuart Samuel, Barbara Peskin, Bhakti Arondekar, et al.
Journal of Clinical Lipidology|September 27, 2012
Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemiaJennifer B Christian, Bhakti Arondekar, Erin K Buysman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 30, 2009
Psychometric evaluation of the Diabetes Symptom Checklist-Revised (DSC-R)--a measure of symptom distressRobert A Arbuckle, Louise Humphrey, Kawitha Vardeva, et al.
Journal of Managed Care & Specialty Pharmacy|November 22, 2021
Payer perceptions on the use of patient-reported outcomes in oncology decision makingGary Oderda, Diana Brixner, Joseph Biskupiak, et al.
Prostate Cancer and Prostatic Diseases|August 17, 2023
The impact of race on survival in metastatic prostate cancer: a systematic literature reviewStephen J Freedland, Imtiaz A Samjoo, Emily Rosta, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 4, 2018
Important Group Differences on the Functional Assessment of Cancer Therapy-Kidney Symptom Index Disease-Related Symptoms in Patients with Metastatic Renal Cell CarcinomaDavid Cella, Robert J Motzer, Brian I Rini, et al.
Journal of Managed Care & Specialty Pharmacy|January 7, 2015
Health care costs among renal cancer patients using pazopanib and sunitinibRyan N Hansen, Michelle D Hackshaw, Saurabh P Nagar, et al.
Plos One|September 11, 2013
Cost-effectiveness analysis of Tdap in the prevention of pertussis in the elderlyLisa J McGarry, Girishanthy Krishnarajah, Gregory Hill, et al.
Pageof 5